Junfang Zheng | Molecular Biology Award | Best Researcher Award

Dr. Junfang Zheng | Molecular Biology Award | Best Researcher Award

Dr. Junfang Zheng, Capital medical university, China

Based on Dr. Junfang Zheng’s academic background, current and previous appointments, and honors and awards, he appears to be a strong candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Scopus

Education:

Dr. Zheng has a solid educational foundation with a B.M. in Traditional Chinese Medicine from Shanxi University of Chinese Medicine, followed by an M.Sc. in Diagnostics of Traditional Chinese Medicine from Beijing University of Chinese Medicine. His Ph.D. in Pathogenic Biology from Peking University further strengthens his expertise, indicating a robust background in both traditional and modern aspects of medical research.

Current Appointment:

Since 2006, Dr. Zheng has been a Professor in the Department of Biochemistry and Molecular Biology at Capital Medical University. This long-term position reflects his established career and significant contributions to his field.

Previous Appointments:

Dr. Zheng’s previous roles include a Visiting Fellow at the Medical University of Vienna and a Postdoctoral Fellow at Tsinghua University. These positions highlight his international experience and commitment to advancing his research in different academic environments.

Honors, Awards, and Grants:

Dr. Zheng has received multiple prestigious awards, including the Guanghua Fellowship from Peking University, the Eurasia Pacific Uninet Scholarship from Austria, and several funds and honors from Beijing and China. These recognitions underscore his high-impact research contributions and the esteem in which he is held within the academic community.

Publication Top Notes  

  • YTHDF3 phase separation regulates HSPA13-dependent clear cell renal cell carcinoma development and immune evasion 🧬 — Cancer Science, 2024, 0 citations
  • PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway 🧪 — Cell Death and Disease, 2024, 0 citations
  • ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma 🔬 — International Journal of Molecular Sciences, 2023, 2 citations
  • GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway 🧫 — Frontiers in Oncology, 2022, 6 citations
  • Inhibitor tolerance and bioethanol fermentability of levoglucosan-utilizing Escherichia coli were enhanced by overexpression of stress-responsive gene ycfR 🔬 — Synthetic and Systems Biotechnology, 2021, 4 citations
  • Bioactive peptide apelin rescues acute kidney injury by protecting the function of renal tubular mitochondria 🧬 — Amino Acids, 2021, 11 citations
  • SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis 🧪 — Frontiers in Oncology, 2021, 28 citations
  • iTRAQ-facilitated proteomic analysis of Bacillus cereus via degradation of malachite green 🔬 — Journal of Microbiology, 2021, 2 citations
  • Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation 🧬 — Oncogene, 2020, 26 citations
  • ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation 🔬 — Biomedicine and Pharmacotherapy, 2020, 16 citations


Conclusion

Dr. Zheng’s extensive educational background, notable appointments, and numerous awards make him a highly suitable candidate for the Research for Best Researcher Award. His achievements and international experience align well with the criteria for such an award.

Wael El-Sayed | Biochemistry | Best Researcher Award

Prof Dr. Wael El-Sayed | Biochemistry | Best Researcher Award

Professor, Faculty of Science – Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Animal Physiology and Toxicology at Ain Shams University, Cairo, Egypt. With over 30 years of experience, he has made significant contributions to physiology, toxicology, and drug development. His research, which spans natural products, drug interactions, and biochemical toxicology, has garnered him a notable academic reputation. Dr. El-Sayed holds an impressive record with 78 articles in international peer-reviewed journals and has been cited over 1,400 times. 🌍📚

 

Publication Profile

 

Strengths for the Award:

  1. Extensive Research Output: Dr. Wael M. El-Sayed has published 78 articles in international peer-reviewed journals, which demonstrates a strong commitment to advancing scientific knowledge in toxicology and physiology.
  2. Impact and Recognition: His work has garnered significant recognition in the scientific community, with a high number of citations across Google Scholar (1462), Scopus (1108), and ResearchGate (1242). His h-index values (22 on Google Scholar, 21 on Scopus, and 20 on ResearchGate) further indicate the influence and relevance of his research.
  3. Diverse Research Platforms: Dr. El-Sayed maintains active profiles on multiple research platforms, including Scopus, ORCID, Web of Science, and ResearchGate, which reflects his engagement with the broader scientific community and his dedication to maintaining visibility and accessibility of his work.
  4. Experience and Expertise: As a Professor of Toxicology and Physiology at a reputable institution (University of Ain Shams), Dr. El-Sayed has significant academic and research experience, further solidifying his expertise in his field.

Areas for Improvement:

  1. Interdisciplinary Collaboration: While Dr. El-Sayed has a strong background in toxicology and physiology, increasing collaboration with researchers in other related fields (e.g., molecular biology, environmental science) could potentially expand the impact and applicability of his research.
  2. Research Funding and Projects: Securing more prominent research grants and leading high-impact projects could further enhance Dr. El-Sayed’s research profile, providing additional resources and opportunities to advance his work.
  3. Global Recognition: While Dr. El-Sayed has significant citations and publications, expanding his research reach through international conferences, collaborations, and workshops could increase his global recognition and further establish him as a leading expert in his field.

 

Education 🎓

Ph.D. in Physiology from Ain Shams University, Egypt, and the University of Utah, USA (2003). Thesis: “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats. “M.Sc. in Physiology from Ain Shams University, Cairo, Egypt (1999). Thesis: “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats. “B.Sc. in Science from Ain Shams University, Cairo, Egypt (1993).

Experience 💼

Professor of Animal Physiology and Toxicology, Zoology Department, Ain Shams University (2014-Present). Associate Professor, Zoology Department, Ain Shams University (2009-2014). Associate Professor, Biology Department, King Faisal University, KSA (2007-2013). Assistant Professor, Zoology Department, Ain Shams University (2003-2009). Post-Doctoral Fellow, Department of Pharmacology and Toxicology, University of Utah (2004-2006). Assistant Lecturer and Demonstrator at Ain Shams University (1994-1999).

Research Focus 🔬

Dr. El-Sayed’s research interests include:

Natural products and their therapeutic effects, Drug-drug interactions and drug metabolism, Chemoprotection and chemoprevention strategies in cancer, Antioxidants and biochemical toxicology, Molecular Biology and Biotechnology

Awards and Honours 🏆

2020: Impact of Zinc Oxide-Sea Lettuce Nanocomposite study funded by STDF. 2018: Novel bithiophenes synthesis and anticancer activity project funded by Mansoura University. 2017: Molecular and biological characterization of recombinant human interferon alpha 2b, funded by STDF.

Publication Top Notes 📑

Ahmed DH, El-Beih NM, El-Hussieny EA, El-Sayed WM. “Large diameter zinc oxide nanoparticles reduced testicular CYP17A1 and viability and elevated testicular inflammation in adult male rats.” Under Review.

EL-Azma MHA, EL-Beih NM, EL-Shamy KA, Koriem KMM, EL-Kassaby MI, EL-Sayed WM. “Pumpkin seed oil exerted antidepressant effects through ameliorating oxidative stress and neuroinflammation in the hippocampus of depressed rats.” Under Review.

Mahmoud MM, El-Batran SA, Hegazy R, El-Sayed WM. “Taurine and enzymatically modified isoquercitrin synergistically protect against methotrexate-induced cardiotoxicity in rats: antioxidant and antiapoptotic effects.” Under Review.

Qasem HH, El-Sayed WM. “The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions.” Under Review.

AbdulKhaliq RJ; Alwandawi1 TK, Al-Hamadani MYI, El-Sayed WM. “Immunological Impact of Vaccination on INF-γ and TNF-α Levels: Gender Disparities and Infection Status Modulation in Iraq Subjects.” Under review.

 

Conclusion:

Dr. Wael M. El-Sayed is a highly qualified candidate for the Best Researcher Award, with a strong research background, significant contributions to his field, and a well-established presence in the scientific community. His extensive publication record and high citation count demonstrate his influence in toxicology and physiology. However, there is potential for further growth through interdisciplinary collaboration, increased research funding, and greater global engagement. Overall, Dr. El-Sayed’s achievements and ongoing contributions make him a compelling candidate for this award.